KAYLA JAMIESON: Open Payments
NPI 1184211054 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 61 payments from 21 companies in 2025. Trend: 2023 $748 · 2024 $865 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $280 |
| AstraZeneca Pharmaceuticals LP | 6 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $173 |
| Exact Sciences Corporation | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Organon LLC | 2 | $41 |
| Lundbeck LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
Products named: VRAYLAR, CAPLYTA, BREZTRI, UBRELVY, REXULTI, NEXPLANON, Cologuard Collection Kit, SPRAVATO.
Industry payments across MO — which companies pay providers there.
